Clinical Trial Update: A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer [Phase 1]

View source ↗

Summary

This is an update on a Phase 1 trial of MLN2704 in metastatic androgen-independent prostate cancer, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• MLN2704

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED